Created date

Published on

You are here:

MS in the media - 4 November 2016

29 October - 4 November

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Work capability assessment to be reviewed

The government has announced a consultation on the way claimants for disability benefits are assessed in an attempt to help more people into work. The Department for Work and Pensions is to look at ways to improve Work Capability Assessments that are used to indicate the level of Employment Support Allowance (ESA) that someone can claim.

Source: Guardian
Source: Independent
Source: Independent
Source: Daily Mirror
Source: BBC
Source: ITV

MS Trust link: New employment support for people with disabilities - news item
MS Trust link: Benefits

Rituximab

A study of people taking rituximab at centres in Sweden found the drug was associated with low relapse rates and fewer new lesions seen on MRI. Article includes discussion of the use of rituximab off label when ocrelizumab - a similar drug expected to be much more expensive - gets a licence.

Source: MedPage Today

MS Trust link: Drugs in development

MS and breast cancer

A study using Swedish health records found no association between MS and breast cancer in premenopausal women. There was a higher postmenopausal risk, though the researchers suggest this may be due to greater contact with medical services by people who have MS than in the comparison group.

Source: MS News Today

MS Trust link: Research into MS and other health conditions - news item

Fampridine

A study of fampridine (Fampyra) in 132 people with MS found the drug improved both walking ability and psychological well-being

Source: MS News Today

MS Trust link: Fampridine (Fampyra)

Living up north could speed up onset of MS

New research which analysed more than 30,000 medical records held in MSBase, an international MS registry, suggests that people living in more northerly climes get MS symptoms almost two years earlier.

Source: Daily Mail
Source: Guardian

MS Trust link: Causes of MS